Skip to content

Key Indicators

NACTRC aims to provide the research community with the highest level of support. As part of this commitment, we’ll be publishing key indicators here on our website.

Type of Clinical Agreement & Activity Types Approximate Timeframe
1 – High complexity
  • High risk matters: clinical trial agreements involving a CRO, foreign legal jurisdiction, biosafety considerations, etc.
  • Multi-party/project agreements: Collaboration, Master, Subsite, etc.
Varies, but typically 90-120 business days plus
2 – Intermediate complexity
  • Routine clinical trial agreements directly with Pharma
Varies, but typically 60-90 business days
3 – Routine
  • Agreements for compassionate use, confidential disclosure and amendments.
  • General forms and declarations
  • Work orders to master agreements
Varies, but typically less than 60 business days